Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants

Detalles Bibliográficos
Autores principales: Zheng, Qianqian, Duan, Liangwei, Jiang, Zhihua, Gu, Tingxuan, Zhang, Bojie, Li, Jiaoyang, Zhang, Yang, Zhang, Shiyu, Liang, Yinming, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2022
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170589/
https://www.ncbi.nlm.nih.gov/pubmed/35694375
http://dx.doi.org/10.1016/j.gendis.2022.05.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170589/
https://www.ncbi.nlm.nih.gov/pubmed/35694375
http://dx.doi.org/10.1016/j.gendis.2022.05.027

Ejemplares similares